Clinical trials
Completed Observational Glioblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 4 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 81 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Juan M Garcia-Gomez | 3 |
| Merck Sharp & Dohme LLC | 3 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| Eisai Co., Ltd. | 2 |
| Hospital del Rio Hortega | 2 |
| Maastricht Radiation Oncology | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| University of California, San Francisco | 2 |
| Washington University School of Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 81 |
| Glioma | 29 |
| Brain Neoplasms | 21 |
| Astrocytoma | 17 |
| Gliosarcoma | 11 |
| Central Nervous System Neoplasms | 9 |
| Oligodendroglioma | 7 |
| Breast Neoplasms | 5 |
| Medulloblastoma | 5 |
| Colorectal Neoplasms | 4 |
Trials
Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.